August 30, 2010
MESSAGE FROM THE DIRECTOR
Dear Cancer Center members and investigators:
The Cancer Center announces the first scientific series seminar of the fall semester. The fall is always an exciting and revitalizing time around campus, and what better way to kick off a new academic year than catching up on the innovative research being conducted by your colleagues?
Today's Case CCC Scientific Series will feature updates on research collaborations made possible by pilot funding through the Multi-Investigator Grant Initiative to Promote the Basic Science Scientific Focus Group Areas of the Cancer Center. Three of the funded teams will be presenting:
These projects represent terrific collaborative science that address important basic science questions in cancer. The talks will all be outstanding from highly qualified investigators. We will have a discussion after each talk and at the end as we look towards broader applications and impact of these studies.
Please join us today, August 30 in Wolstein Auditorium. Presentations start at 4 pm, and should end around 5:30, followed by a discussion until 6 and a reception. For those of you who will come over for the seminar, parking validation will be gladly provided.
I hope to see you all there!
Stan Gerson, MD
CASE CCC IN THE NEWS
This Week on Kaleidoscope
The official Case CCC logo is available on the templates page of the Cancer Center website. Co-branded PowerPoint templates are also available on that page.
As a reminder, the NCI-designated Comprehensive Cancer Center logo may only be used in conjunction with the Case CCC logo.
Translational Technology Concept Studies of Circulating Tumor and Endothelial Cells (CTC/CEC)
Message from Dr. Ernest Borden
The CTC/CEC core has initiated several investigator-initiated pilot studies and has begun to see planning for those which will be externally funded. We continue to encourage you, however, to develop new ideas for exploring and validating this technology. In addition to quantitation of these rare circulating cells, we are also now ready to undertake isolation of macromolecules for analysis. The isolated preparations will be provided back to you for assessment of expression in your laboratory or that of a collaborator.
These proposals should involve pilot studies for which technical feasibility and preliminary data needs to be established in order to lead to external funding and would normally be for evaluation of 10-20 samples. We will require the following information (limited to 1 page) for consideration for pilot studies:
If you have any questions please do not hesitate to discuss with John Pellecchia or Ernest Borden. Please submit your 1 page proposals to John Pellecchia. Final approval to proceed with your pilot study will be granted by Derek Raghavan and Ernest Borden and should normally be available within a week of submission.
Choose Ohio First Scholarship And Tomas & Evelyn James Fellowship In Bioinformatics, Computational Biology and Medical Informatics
The primary objective of the Choose Ohio First Scholarship (COF) Program is to support increased higher education participation and success of Ohio students in bioinformatics, computational biology and medical informatics, through the development and implementation of innovative curricular and programs, and in so doing, to advance the economic growth of the state.
Both undergraduate and graduate students who are residents of Ohio, with a minimum GPA of 3.0, and have a background compatible with academic excellence and leadership development in Biomedical Informatics are eligible to apply.
Deadline: September 15
CALL FOR ABSTRACTS
2011 Clinical and Translational Research and Education Meeting: ACRT/SCTS Joint Annual Meeting
Abstracts are now being accepted for the ACRT/SCTS Joint Annual Meeting, April 27-29, 2011 at the Omni Shoreham in Washington, DC. This meeting boasts integration between disciplines and shared successes from bench to bedside-Embracing the Full Spectrum of Translational Research.
Submission Deadline: December 16
**All events are open to anyone interested in attending
Taussig Cancer Institute Core Curriculum Series
Pathology Research Seminar
ICC Grand Rounds
Taussig Cancer Institute Grand Rounds Canceled
Hematology and Oncology Fellows
Cancer Center Research in Progress Seminar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Cancer Center Scientific Series
Cancer Center Scientific Series
ADDITIONAL UPCOMING SEMINARS & EVENTS
Clinical Proteomic Technologies for Cancer (CPTC) 2010 Annual Meeting
2010 caBIG Annual Meeting: Building a Collaborative Biomedical Network
2010 Cleveland Nanomedicine Summit
International Symposium on Breast Cancer Prevention: Nutrition, Communication and Public Policy
ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer
Graft versus Host Disease Conference
Active Living Research Annual Conference
CASE CCC SEED FUNDING
Request for Proposals: Cancer Stem Cell and Cancer Originating Cell Research Projects
The Case Comprehensive Cancer Center will provide seed money to foster collaborations and to promote and increase institution-wide capacity and competitiveness in cancer stem cell and cancer originating cell based research. Four awards of $50,000 will be made to investigators who intend to gather preliminary data to be used in seeking future independently funded programs and support. Case Comprehensive Cancer Center members with a faculty appointment at all levels (eligible to apply for independent nationally competitive research grants) are encouraged to apply. Proposals from both junior and senior investigators are encouraged. Postdoctoral fellows, graduate students and research associates are not eligible to apply for these pilot grants.
It is expected that these grants will represent new initiatives, not otherwise funded in new areas of cancer stem cell research. Use of animal models of human disease, primary cancer stem cells and cancer originating cells isolated from human cancers, development of novel cell lines such as iPS of human cancers, and methods development for the isolation of cancer stem cells and cancer originating cell based would be responsive. The NIH ARRA award mechanism will be the source of funds for 2 awards, with matching funds for the additional two awards. Investigators should identify the Cancer Center Scientific Program under which this pilot application is submitted and have a letter from the Program Leader acknowledging the programmatic alignment. Program Leaders can be found on the Cancer Center web site.
Deadline: September 10
Details are available on the cancer center website.
Request for Proposals: Basic, Clinical, or Translational Human Tissue Based Cancer Research Projects
The Case CCC will provide seed money to foster collaborations and to promote and increase institution-wide capacity and competitiveness in basic, clinical or translational human tissue based research.
Three awards of $50,000 and three awards at $20,000 apiece will be awarded to investigators who intend to gather preliminary data to be used in seeking future independently funded programs and support.
Case CCC members with a faculty appointment at all levels (eligible to apply for independent nationally competitive research grants) are encouraged to apply. Proposals from both junior and senior investigators are encouraged. Postdoctoral fellows, graduate students and research associates are not eligible to apply for these pilot grants. It is expected that these grants will represent collaborative efforts between lab based or quantitative science-based and clinical investigators, likely a clinician who is a member of the disease team of the tissue research in question.
Deadline: September 10
Details are available on the cancer center website.
MARK YOUR CALENDARS
Stand Up to Cancer (SU2C), a new initiative created with a focus on funding high impact cancer research, is getting ready for their next telecast on September 10 at 8 pm. The broadcast will be dedicated to the 12 million U.S. cancer survivors and illustrate how groundbreaking research can change the tide in the fight against the disease. This year's telecast will feature live performances from legendary recording artists and stars in film, television, and sports. It will focus not only on scientific research, but also on survivorship and how patients can have quality of life after diagnosis and treatment. Viewership is vital because donations from the public will sustain this critical cancer research.
Third Annual Personalized Health Care National Conference
Registration is now open for "Advancing Predictive, Preventive, Personalized and Participatory (P4) Medicine," October 14-15 at The Ohio State University. The Third Annual Conference on Personalized Medicine features internationally renowned experts and leaders in personalized medicine, including keynote speakers Dr. Leroy Hood of the Institute for Systems Biology, Dr. Ralph Snyderman of Duke University and Dr. Greg Downing of the U.S. Department of Health and Human Services. The keynote speakers together with a large panel of academic and industry experts will share their insights on the latest developments and the future of personalized medicine. The major theme of the conference will focus on advancing the development of the P4 Medicine paradigm: predictive, preventive, personalized and participatory healthcare. This new paradigm will involve developing innovations in the health care delivery model, patient engagement, applications of genetics/genomics in clinical medicine, breakthroughs in science and technologies in healthcare, and the challenges of making personalized health care a reality. This conference will bring together academic leaders, industry experts, government policy makers and health care providers from around the nation to discuss the latest developments in personalized medicine research and the challenges of translating these discoveries into clinical practice.
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES
Induced Pluripotent Stem Cell Pilot Research Award
William Lawrence & Blanche Hughes Foundation
NIH BULLETIN – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to email@example.com.